NFE2L2 and glaucoma: A recent study [14] supported the role of oxidative stress in a model of glaucoma and the important contribution of the endogenous antioxidant Nrf2 pathway to slow the onset of neurodegeneration after the induction of ocular hypertension and that this pathway represents an optimal therapeutic target for glaucoma therapies [12].